280 results on '"Minor, Philip D."'
Search Results
2. Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom
3. Detection of bovine viral diarrhoea virus nucleic acid, but not infectious virus, in bovine serum used for human vaccine manufacture
4. Scientific consultation on the safety and containment of new poliovirus strains for vaccine production, clinical/regulatory testing and research. Report of a meeting held at NIBSC, Potters Bar, Hertfordshire, UK, 6/7th July 2016
5. A collaborative study to establish the 3rd WHO International Standard for hepatitis B virus for nucleic acid amplification techniques
6. A collaborative study to establish the 1st WHO International Standard for Epstein–Barr virus for nucleic acid amplification techniques
7. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology
8. Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing
9. Production of high titer attenuated poliovirus strains on the serum-free PER.C6® cell culture platform for the generation of safe and affordable next generation IPV
10. High resolution identity testing of inactivated poliovirus vaccines
11. Comparing viral metagenomics methods using a highly multiplexed human viral pathogens reagent
12. Interruption of Poliovirus Transmission in Ghana: Molecular Epidemiology of Wild-Type 1 Poliovirus Isolated from 1995 to 2008
13. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication
14. When Can We Stop Using Oral Poliovirus Vaccine?
15. Comparison of the Complete Nucleotide Sequences of the Genomes of the Neurovirulent Poliovirus P3/Leon/37 and Its Attenuated Sabin Vaccine Derivative P3/Leon 12a 1 b
16. Vaccine Strategies
17. Development of working reference materials for clinical virology
18. Vaccines against seasonal and pandemic influenza and the implications of changes in substrates for virus production
19. Novel parvovirus and related variant in human plasma
20. Polio eradication, cessation of vaccination and re-emergence of disease
21. Expert Review on Poliovirus Immunity and Transmission
22. Review and Assessment of Poliovirus Immunity and Transmission: Synthesis of Knowledge Gaps and Identification of Research Needs
23. Species differences in the cerebellar distribution of six members of the Kv1 channel subfamily
24. Failure to Detect Measles Virus Ribonucleic Acid in Bone Cells from Patients with Paget’s Disease
25. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma
26. POLIOVIRUSES (PICORNAVIRIDAE) | General Features
27. Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans
28. Polio vaccines and the cessation of vaccination
29. Continued use of poliovirus after eradication: hyper‐attenuated strains as a safe alternative for release testing of human immunoglobulins
30. Measles vaccination as a risk factor for inflammatory bowel disease
31. Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes
32. Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection
33. Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines
34. Coding Changes in the Poliovirus Protease 2A Compensate for 5′NCR Domain V Disruptions in a Cell-Specific Manner
35. Environmental Surveillance Reveals Complex Enterovirus Circulation Patterns in Human Populations
36. Report of the international conference on next generation sequencing for adventitious virus detection in biologicals
37. Isolation of Vaccine-Like Poliovirus Strains in Sewage Samples From the United Kingdom
38. Molecular and Biological Changes Associated with HeLa Cell Attenuation of Wild-Type Yellow Fever Virus
39. Mumps Viruses And Mumps, Measles, And Rubella Vaccine
40. Genetically Thermo-Stabilised, Immunogenic Poliovirus Empty Capsids; a Strategy for Non-replicating Vaccines
41. Commutability of the World Health Organization International Standard for Human Cytomegalovirus: Standard or Assay
42. WHO collaborative study to assess the suitability of an interim standard for antibodies to Ebola virus
43. A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology
44. Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing
45. New Strains Intended for the Production of Inactivated Polio Vaccine at Low-Containment After Eradication
46. Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays
47. Expert Review on Poliovirus Immunity and Transmission
48. Use of Vaccines to Eradicate Infectious Disease
49. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative
50. Live attenuated vaccines: Historical successes and current challenges
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.